FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072386 [Registered on: 12/08/2024] Trial Registered Prospectively
Last Modified On: 22/08/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Comparative Clinical Study of Unani Formulations in the Management of Abnormal Vaginal Discharge 
Scientific Title of Study   Comparative Clinical Study of Unani Formulations in the Management of Bacterial Vaginosis 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rushda Fatma 
Designation  PG Scholar 
Affiliation  State Takmeel Uttib College and Hospital Lucknow 
Address  Department of Ilmul Qabalat wa Amraze Niswan State Takmeel Uttib College and Hospital Lucknow Near Ramabai Raily Sthal Bijnor Road Aurangabad Tiraha Lucknow

Lucknow
UTTAR PRADESH
226002
India 
Phone  8887698311  
Fax    
Email  rushda0601@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mani Ram Singh 
Designation  Reader 
Affiliation  State Takmeel Uttib College and Hospital Lucknow 
Address  Department of Ilmul Qabalat wa Amraze Niswan State Takmeel Uttib College and Hospital Lucknow Near Ramabai Raily Sthal Bijnor Road Aurangabad Tiraha Lucknow

Lucknow
UTTAR PRADESH
226002
India 
Phone  8423307654  
Fax    
Email  dr_maniramsingh@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mani Ram Singh 
Designation  Reader 
Affiliation  State Takmeel Uttib College and Hospital Lucknow 
Address  Department of Ilmul Qabalat wa Amraze Niswan State Takmeel Uttib College and Hospital Lucknow Near Ramabai Raily Sthal Bijnor Road Aurangabad Tiraha Lucknow

Lucknow
UTTAR PRADESH
226002
India 
Phone  8423307654  
Fax    
Email  dr_maniramsingh@rediffmail.com  
 
Source of Monetary or Material Support  
State Takmeel Uttib College and Hospital Near Ramabai Raily Sthal Aurangabad Tiraha lucknow Uttar Pradesh India 226002  
 
Primary Sponsor  
Name  State Takmeel Uttib College And Hospital 
Address  Near Ramabai Raily Sthal Bijnor Road Aurangabad Tiraha Lucknow Uttar Pradesh India 226002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rushda Fatma  State Takmeel Uttib College and Hospital  OPD No 111 Department of Ilmul Qabalat wa Amraze Niswan
Lucknow
UTTAR PRADESH 
8887698311

rushda0601@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE STATE TAKMEEL UTTIB COLLEGE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N899||Noninflammatory disorder of vagina, unspecified, (2) ICD-10 Condition: N898||Other specified noninflammatory disorders of vagina,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Ma‘jÅ«n Mochras Mochras Firzaja  Ma‘jÅ«n Mochras 10gm orally with water in the morning daily and Mochras Firzaja per vaginum daily at bedtime for the duration of 3 weeks 
Comparator Agent  Ma‘jÅ«n Mochras   Ma‘jÅ«n Mochras 10gm orally with water in the morning daily for the duration of 3 weeks  
Intervention  MOCHRAS FIRZAJA   Mochras Firzaja per vaginum daily at bedtime for the duration of 3 weeks  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Married women above the age of 18 years with regular menstrual cycle
Complain of vaginal discharge associated with low backache lower abdominal pain
and vulvae itching
ï‚· Positive Amsel’s criteria  
 
ExclusionCriteria 
Details  Pregnant, lactating and menopausal women
Women on antibiotics and hormones in present and recent past
Women with IUCDs
Women with other pelvic pathology STDs genital prolapse and unhealthy cervix
Women with known history of systemic and endocrinal diseases  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Clinical cure defined as resolution of subjective symptoms of vaginal discharge
backache lower abdominal pain and vulval itching assessed by VAS  
Baseline
1st Week
2nd Week
3rd Week 
 
Secondary Outcome  
Outcome  TimePoints 
Negative Whiff test Normalization of vaginal pH Negative saline mount and
decreased Clue cells  
Before Treatment
After Treatment 
 
Target Sample Size   Total Sample Size="75"
Sample Size from India="75" 
Final Enrollment numbers achieved (Total)= "75"
Final Enrollment numbers achieved (India)="68" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   23/08/2024 
Date of Study Completion (India) 24/10/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 24/10/2025 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patients meeting all the inclusion criteria will be randomly allocated to either of the three test groups (n=25 in each groups) after taking their consent. In one group, Mochras Firzaja per vaginum will be given daily at bedtime. In second group, Ma‘jÅ«n Mochras 10gm will be given orally with water for duration of 3 weeks. In third group, Ma‘jÅ«n Mochras 10gm orally with water will be given in the morning daily along with Mochras Firzaja per vaginum daily at bedtime for the duration of 3 weeks. . Follow up will be done on weekly basis during the treatment and post treatment follow ups fortnightly will be done after completion of the treatment. Subjective parameters will be assessed on each visit while objective parameters will be assessed before and after completion of the treatment.  
Close